Recurve Capital, an investment management company, released its Q4 2024 investor letter. Recurve had an impressive performance in 2024, successfully bouncing back from the drawdown experienced in 2022 ...

Fred Alger Management, an investment management company, released its “Alger Spectra Fund” fourth quarter 2024 investor ...

Michael Nierenberg, Chairman, CEO, and President, highlighted a strong Q4 2024 performance, including GAAP net income of $263 million or $0.50 per diluted share. He emphasized a return on equity of 16 ...

Bristol-Myers Squibb (BMY) to announce Q4 earnings on February 6th. Analysts expect $1.47 EPS on $11.56B revenue.